Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Early and late virologic failure following virologic suppression in HIV-infected Asian children and adolescents.

Mu W, Bartlett AW, Bunupuradah T, Chokephaibulkit K, Kumarasamy N, Ly PS, Hansudewechakul R, Van Lam N, Lumbiganon P, Sudjaritruk T, Jamal Mohamed TA, Nik Yusoff NK, Khanh TH, Viet DC, Fong MS, Nallusamy R, Kurniati N, Wati DK, Sohn AH, Kariminia A, Zhang F; TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific.

J Acquir Immune Defic Syndr. 2018 Nov 20. doi: 10.1097/QAI.0000000000001921. [Epub ahead of print]

PMID:
30531299
2.

A Qualitative Exploration of Psychosocial Challenges of Perinatally HIV-Infected Adolescents and Families in Bangkok, Thailand.

Nestadt DF, Lakhonpon S, Pardo G, Saisaengjan C, Gopalan P, Bunupuradah T, McKay MM, Ananworanich J, Mellins CA.

Vulnerable Child Youth Stud. 2018;13(2):158-169. doi: 10.1080/17450128.2017.1356947. Epub 2017 Jul 21.

3.

Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.

Aurpibul L, Kariminia A, Vibol U, Fong MS, Le ON, Hansudewechakul R, Bunupuradah T, Kurniati N, Chokephaibulkit K, Kumarasamy N, Wati DK, Yusoff NKN, Razali KAM, Nallusamy RA, Sohn AH, Lumbiganon P; TREAT Asia Pediatric HIV Observational Database (TApHOD) of IeDEA Asia-Pacific.

Pediatr Infect Dis J. 2018 Aug;37(8):788-793. doi: 10.1097/INF.0000000000001901.

PMID:
29846357
4.

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.

Turkova A, Moore CL, Butler K, Compagnucci A, Saïdi Y, Musiime V, Nanduudu A, Kaudha E, Cressey TR, Chalermpantmetagul S, Scott K, Harper L, Montero S, Riault Y, Bunupuradah T, Volokha A, Flynn PM, Bologna R, Ramos Amador JT, Welch SB, Nastouli E, Klein N, Giaquinto C, Ford D, Babiker A, Gibb DM; BREATHER (PENTA 16) trial Group.

PLoS One. 2018 Apr 23;13(4):e0196239. doi: 10.1371/journal.pone.0196239. eCollection 2018.

5.

Effect of calcium and vitamin D supplementation on bone mineral accrual among HIV-infected Thai adolescents with low bone mineral density.

Puthanakit T, Wittawatmongkol O, Poomlek V, Sudjaritruk T, Brukesawan C, Bunupuradah T, Sricharoenchai S, Chuanjaroen T, Prasitsuebsai W, Chokephaibulkit K.

J Virus Erad. 2018 Jan 1;4(1):6-11.

6.

Cultural Adaptation of an Evidence-Informed Psychosocial Intervention to Address the Needs of PHIV+ Youth in Thailand.

Pardo G, Saisaengjan C, Gopalan P, Ananworanich J, Lakhonpon S, Nestadt DF, Bunupuradah T, Mellins CA, McKay MM.

Glob Soc Welf. 2017;4(4):209-218. doi: 10.1007/s40609-017-0100-x. Epub 2017 Jul 24.

7.

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents.

Jantarabenjakul W, Anugulruengkitt S, Kasipong N, Thammajaruk N, Sophonphan J, Bunupuradah T, Cressey TR, Colbers A, Burger DM, Phongsamart W, Puthanakit T, Pancharoen C; HIVNAT 220 study.

Antivir Ther. 2018;23(3):259-265. doi: 10.3851/IMP3198.

PMID:
28994660
8.

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.

Boerma RS, Bunupuradah T, Dow D, Fokam J, Kariminia A, Lehman D, Kityo C, Musiime V, Palumbo P, Schoffelen A, Sophan S, Zanoni B, Rinke de Wit TF, Calis JCJ, Sigaloff KCE; Paediatric Second-line Study Group.

J Int AIDS Soc. 2017 Sep 15;20(1):21930. doi: 10.7448/IAS.20.1.21930.

9.

Strategies to improve the uptake of effective contraception in perinatally HIV-infected adolescents.

Landolt NK, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Kerr S, Boonyanurak P, Ananworanich J, Bunupuradah T.

J Virus Erad. 2017 Jul 1;3(3):152-156.

10.

Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents.

Bunupuradah T, Phupitakphol T, Sophonphan J, Prasitsuebsai W, Anugulruengkitt S, Jantarabenjakul W, Sopa B, Ruxrungtham K, Chanakul A, Puthanakit T; HIV-NAT 015 Study Team.

Pediatr Infect Dis J. 2018 Jan;37(1):66-70. doi: 10.1097/INF.0000000000001684.

PMID:
28719505
11.

Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand.

Teeraananchai S, Kerr SJ, Puthanakit T, Bunupuradah T, Ruxrungtham K, Chaivooth S, Law MG, Chokephaibulkit K.

J Pediatr. 2017 Sep;188:210-216.e1. doi: 10.1016/j.jpeds.2017.05.035. Epub 2017 Jun 9.

PMID:
28606372
12.

Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium.

Brown SA, Abbas S, Davies MA, Bunupuradah T, Sohn AH, Technau KG, Renner L, Leroy V, Edmonds A, Yotebieng M, McGowan CC, Duda SN, Mofenson L, Musick B, Wools-Kaloustian K.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):60-64. doi: 10.1097/QAI.0000000000001453.

13.

First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand.

Teeraananchai S, Bunupuradah T, Puthanakit T, Kerr SJ, Ruxrungtham K, Chaivooth S, Bhakeecheep S, Law MG, Chokephaibulkit K.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):219-225. doi: 10.1097/QAI.0000000000001351.

PMID:
28498146
14.

Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy.

Sudjaritruk T, Aurpibul L, Ly PS, Le TPK, Bunupuradah T, Hansudewechakul R, Lumbiganon P, Chokephaibulkit K, Nik Yusoff NK, Nguyen LV, Mohd Razali KA, Fong MS, Nallusamy RA, Kurniati N, Do VC, Boettiger DC, Sohn AH, Kariminia A.

J Adolesc Health. 2017 Jul;61(1):91-98. doi: 10.1016/j.jadohealth.2017.01.014. Epub 2017 Mar 24.

15.

Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception.

Kancheva Landolt N, Bunupuradah T, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Ubolyam S, Thammajaruk N, Kerr S, Ananworanich J.

J Virus Erad. 2017 Jan 1;3(1):56-60.

16.

HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes.

Lumbiganon P, Kosalaraksa P, Bunupuradah T, Boettiger D, Saphonn V, Truong KH, Kurniati N, Hansudewechakul R, Do VC, Sudjaritruk T, Kumarasamy N, Kongstan N, Yusoff NK, Nguyen LV, Wati DK, Razali K, Sohn AH, Kariminia A.

Asian Biomed (Res Rev News). 2016 Jun;10(3):229-234.

17.

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.

Prévost J, Zoubchenok D, Richard J, Veillette M, Pacheco B, Coutu M, Brassard N, Parsons MS, Ruxrungtham K, Bunupuradah T, Tovanabutra S, Hwang KK, Moody MA, Haynes BF, Bonsignori M, Sodroski J, Kaufmann DE, Shaw GM, Chenine AL, Finzi A.

J Virol. 2017 Mar 13;91(7). pii: e02452-16. doi: 10.1128/JVI.02452-16. Print 2017 Apr 1.

18.

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents.

Aurpibul L, Lumbiganon P, Hansudewechakul R, Kanjanavanit S, Bunupuradah T, Kosalaraksa P, Taeprasert P, Puthanakit T.

Pediatr Infect Dis J. 2017 Apr;36(4):401-404. doi: 10.1097/INF.0000000000001491.

19.

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.

Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Sophonphan J, Ananworanich J, Puthanakit T; Bone-D study group.

Antivir Ther. 2017;22(6):471-479. doi: 10.3851/IMP3103. Epub 2016 Oct 27.

PMID:
27786155
20.

Impact of orphan status on HIV treatment outcomes and retention in care of children and adolescents in Asia.

Huy BV, Teeraananchai S, Oanh LN, Tucker J, Kurniati N, Hansudewechakul R, Truong KH, Khol V, Nguyen LV, Chau Do V, Lumbiganon P, Kongstan N, Bunupuradah T, Sudjaritruk T, Kumarasamy N, Yusoff NK, Mohd Razali KA, Wati DK, Fong MS, Nallusamy R, Kariminia A, Sohn AH.

J Virus Erad. 2016 Oct 5;2(4):227-231.

Supplemental Content

Loading ...
Support Center